Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Epi-GERD Study: Epidemiological Evaluation in Patients With Gastro-Esophageal Reflux

NCT04094402 is registered in ClinicalTrials.gov with Scandinavia Pharma as lead sponsor.

NCT NCT04094402
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04094402 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Epi-GERD Study: Epidemiological Evaluation in Patients With Gastro-Esophageal Reflux
Lead sponsor
Scandinavia Pharma
Phase
Observational
Overall status
Unknown status
Start date
June 4, 2019
Completion date
July 31, 2024
Enrollment
1,500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastroesophageal reflux disease